Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Science Advances
|
June 5, 2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
Yuxiang Wang, Aaron T Wild, Sevin Turcan, et al.
Neuro-Oncology
|
March 26, 2014
Transcriptional diversity of long-term glioblastoma survivors
Naamit K Gerber, Anuj Goenka, Sevin Turcan, et al.
Oncotarget
|
October 1, 2013
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, et al.
Nature Genetics
|
May 6, 2014
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
Yongxing Gong, Travis Ian Zack, Luc G T Morris, et al.
Science Translational Medicine
|
March 25, 2011
Breast cancer methylomes establish an epigenomic foundation for metastasis
Fang Fang, Sevin Turcan, Andreas Rimner, et al.
Nature Genetics
|
November 29, 2017
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
Sevin Turcan, Vladimir Makarov, Julian Taranda, et al.
Nature
|
February 21, 2012
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu, Patrick S Ward, Gurpreet S Kapoor, et al.
Nature
|
February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan, Daniel Rohle, Anuj Goenka, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Nature
|
September 20, 2019
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Varun Venkataramani, Dimitar Ivanov Tanev, Christopher Strahle, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Science Advances
|
June 5, 2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
Yuxiang Wang, Aaron T Wild, Sevin Turcan, et al.
Neuro-Oncology
|
March 26, 2014
Transcriptional diversity of long-term glioblastoma survivors
Naamit K Gerber, Anuj Goenka, Sevin Turcan, et al.
Oncotarget
|
October 1, 2013
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, et al.
Nature Genetics
|
May 6, 2014
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
Yongxing Gong, Travis Ian Zack, Luc G T Morris, et al.
Science Translational Medicine
|
March 25, 2011
Breast cancer methylomes establish an epigenomic foundation for metastasis
Fang Fang, Sevin Turcan, Andreas Rimner, et al.
Nature Genetics
|
November 29, 2017
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
Sevin Turcan, Vladimir Makarov, Julian Taranda, et al.
Nature
|
February 21, 2012
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu, Patrick S Ward, Gurpreet S Kapoor, et al.
Nature
|
February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan, Daniel Rohle, Anuj Goenka, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Nature
|
September 20, 2019
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Varun Venkataramani, Dimitar Ivanov Tanev, Christopher Strahle, et al.
Page
of 4